Viewing nowCombinationFinacab Tablets 60/2.5 mg (Pimasartan Potassium, Esamlodipine)
Fimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Eden Pharma Co., Ltd.

MFDS item code 202300108 · Approved 2023.01.06 · Insurance code 628902200
Treatment of essential hypertension not controlled with fimasartan monotherapy
This medication is used to effectively manage blood pressure in patients with essential hypertension whose blood pressure is not sufficiently controlled with Pimasartan Potassium monotherapy.
The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended to take this medicine at the same time each day (e.g., in the morning), if possible. Before starting this medicine, it is recommended to adjust the dose of fimasartan; however, if blood pressure is not controlled as described below, switching directly to this medicine may be considered. ㆍ 30/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy. ㆍ 60/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy. ㆍ 60/5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy or this medicine 60/2.5 mg. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Older adults No initial dose adjustment is required for older adults aged 70 years or younger. Patients with renal impairment No dose adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with fimasartan 30 mg in this medicine. Patients with hepatic impairment No dose adjustment is required in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate to severe hepatic impairment.
The safety and efficacy of this medicine have not been established in pediatric and adolescent patients aged 18 years or younger.
This medication may cause serious harm to the fetus and newborn when taken during pregnancy, especially in the second and third trimesters; therefore, it should be discontinued immediately upon confirmation of pregnancy. It should not be used in patients with allergies to this drug's main ingredients or similar substances, in pregnant or nursing women, in patients undergoing kidney dialysis, patients with severe liver disease, bile duct obstruction, certain kidney diseases, patients with lactose intolerance, patients with severe aortic stenosis, or in shock. Patients with low blood volume or salt, impaired kidney function, renal artery hypertension, aortic or mitral stenosis, primary aldosteronism, severe hypotension, the elderly, and those allergic to certain pigment components should use this medication with special caution. While taking this medication, side effects such as dizziness, headache, facial swelling, urination disorders, insomnia, and flushing may occur, and serious adverse reactions may occur infrequently; consult a doctor immediately if symptoms arise. Since hypotension may occur, special care should be taken when monitoring during treatment, especially in patients who are on diuretics or have conditions causing decreased blood volume, such as dietary salt restrictions, diarrhea, or vomiting. Due to the risk of increased serum potassium levels, patients with heart failure or impaired kidney function should have regular blood tests. This medication may interact with other antihypertensive drugs or specific medications, so inform your doctor or pharmacist of any other medications being taken. Women who are pregnant or planning to become pregnant should consult a doctor before taking this medication, and nursing mothers should carefully consider whether to continue breastfeeding or taking the medication. Safety and efficacy in children and adolescents have not been established, and use is not recommended for those under 18 years of age. Elderly patients may react more sensitively to this medication, so special caution is necessary during use. Patients with moderate to severe liver disease should not take this medication, and those with impaired liver function should use it cautiously. In case of overdose, hypotension, palpitations, and in severe cases shock may occur; immediate medical attention should be sought for proper treatment. This medication should be kept out of the reach of children, and transferring to other containers is not advisable as it may compromise the quality.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a container that blocks light. Additionally, it is best to store the medication at room temperature between 1 and 30 degrees Celsius. This will help maintain the medication's effectiveness.
Yellow, rounded square film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationFimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Eden Pharma Co., Ltd.
CombinationFimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 7.48mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
NBK Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Ajou Pharmaceuticals Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Kips Biopharma Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Bionex Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.